GENinCode plc

Company Profile

Company website
Sector
Medical Equipment and Services (Medical Services)
Description
GENinCode plc (AIM: GENI) is engaged in the risk assessment, prediction and prevention of cardiovascular disease (“CVD”). CVD is the leading cause of death worldwide accounting for approximately 18 million deaths annually.

Investor Access

02 Oct
Event information

Matthew Walls, Chief Executive Officer, and Paul Foulger, Chief Financial Officer, will provide a live presentation relating to the results via the Investor Meet Company platform on Thursday, 2 October 2025 at 11.00am BST.

Investors can sign up to Investor Meet Company for free and add to meet GENinCode here.

Venue
Online
Time
Thursday, 2 October 2025 at 11.00am BST.
Financial Calendar
 Event Date
Year EndDecember 31
Half  Year End30 June
Preliminary Results*March/April
Interim Results*September
AGM*June

* Months based on previous announcements of this kind